Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CITE

Cartica Acquisition (CITE) Stock Price, News & Analysis

Cartica Acquisition logo

About Cartica Acquisition Stock (NASDAQ:CITE)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$11.85
$11.85
50-Day Range
$11.68
$11.85
52-Week Range
$10.95
$12.25
Volume
407 shs
Average Volume
26,585 shs
Market Capitalization
$94.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify and complete a business combination in the technology sector. Cartica Acquisition Corp was incorporated in 2021 and is based in New York, New York.

Remove Ads
Receive CITE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cartica Acquisition and its competitors with MarketBeat's FREE daily newsletter.

CITE Stock News Headlines

CRTUF Cartica Acquisition Corp Units
Elon Musk is helping print “new gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.
Cartica Acquisition Corp (CITEW)
Cartica Acquisition Corp. Cl A
See More Headlines

CITE Stock Analysis - Frequently Asked Questions

Cartica Acquisition's top institutional shareholders include Decagon Asset Management LLP (7.70%), Mizuho Securities USA LLC (4.21%), Toronto Dominion Bank (1.08%) and Toronto Dominion Bank (1.08%).

Based on aggregate information from My MarketBeat watchlists, some other companies that Cartica Acquisition investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), AI Transportation Acquisition (AITR), Alnylam Pharmaceuticals (ALNY), Alpha Star Acquisition (ALSA) and Amgen (AMGN).

Company Calendar

Today
3/31/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Trading
Current Symbol
NASDAQ:CITE
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
2,552,000
Market Cap
$94.80 million
Optionable
Not Optionable
Beta
0.01
The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report

This page (NASDAQ:CITE) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners